Q2 EPS Estimates for Henry Schein Decreased by William Blair

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at William Blair cut their Q2 2026 EPS estimates for Henry Schein in a note issued to investors on Wednesday, November 5th. William Blair analyst B. Vazquez now forecasts that the company will post earnings of $1.13 per share for the quarter, down from their prior forecast of $1.23. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein’s Q3 2026 earnings at $1.49 EPS, Q4 2026 earnings at $1.36 EPS, Q1 2027 earnings at $1.33 EPS, Q2 2027 earnings at $1.32 EPS, Q3 2027 earnings at $1.46 EPS and FY2027 earnings at $5.54 EPS.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.34 billion during the quarter, compared to the consensus estimate of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS.

A number of other equities research analysts also recently issued reports on HSIC. Weiss Ratings restated a “hold (c-)” rating on shares of Henry Schein in a report on Friday, October 31st. Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Robert W. Baird restated a “neutral” rating and issued a $72.00 target price (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research note on Monday, July 14th. Finally, Morgan Stanley boosted their price objective on shares of Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a research note on Wednesday. Five investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $76.08.

Henry Schein Price Performance

Henry Schein stock opened at $72.01 on Thursday. Henry Schein has a 1 year low of $60.56 and a 1 year high of $82.49. The firm has a 50 day moving average price of $66.23 and a 200 day moving average price of $68.64. The company has a market cap of $8.73 billion, a price-to-earnings ratio of 23.23, a PEG ratio of 2.06 and a beta of 0.84. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Alliancebernstein L.P. raised its stake in shares of Henry Schein by 21.9% in the 1st quarter. Alliancebernstein L.P. now owns 218,340 shares of the company’s stock valued at $14,954,000 after purchasing an additional 39,188 shares in the last quarter. Great Lakes Advisors LLC acquired a new stake in shares of Henry Schein in the 1st quarter valued at about $4,477,000. Swedbank AB raised its stake in shares of Henry Schein by 30.9% in the 2nd quarter. Swedbank AB now owns 1,156,398 shares of the company’s stock valued at $84,475,000 after purchasing an additional 272,913 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Henry Schein by 15.9% in the 1st quarter. Wellington Management Group LLP now owns 7,996 shares of the company’s stock valued at $548,000 after purchasing an additional 1,094 shares in the last quarter. Finally, Zuckerman Investment Group LLC lifted its position in shares of Henry Schein by 69.6% in the 1st quarter. Zuckerman Investment Group LLC now owns 201,639 shares of the company’s stock worth $13,810,000 after buying an additional 82,779 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.